Biosynthetic skin substitute vs. 1% silver sulfadiazine for treatment of inpatient partial-thickness thermal burns.
When used appropriately on superficial or moderate-depth partial-thickness burns, Biobrane significantly decreased total healing time to complete reepithelialization, reduced pain, and was associated with decreased nursing time and costs when compared to 1% silver sulfadiazine cream. Care must be used in selecting wounds for Biobrane therapy. They must be fresh, noninfected, and free of eschar and debris with a moist, sensate surface that demonstrates capillary blanching and refill. Wounds must be inspected regularly for nonadherence and signs of infection. Early fluid accumulation requires prompt aspiration. Biobrane should be removed if fluid reaccumulates or the Biobrane becomes nonadherent at any time after 48 hours. When used appropriately, Biobrane offers significant advantages over conventional therapy of acute partial-thickness burns.
Gerding
R L
RL
Department of Surgery, Cleveland Metropolitan General Hospital, OH 44109.
Imbembo
A L
AL
Fratianne
R B
RB
D000293:Adolescent; D000328:Adult; D001672:Biocompatible Materials / Q000627:therapeutic use*; D002056:Burns / Q000503:physiopathology / Q000628:therapy*; D020099:Coated Materials, Biocompatible; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D008297:Male; D009779:Occlusive Dressings / Q000191:economics; D009824:Ointments; D011446:Prospective Studies; D011897:Random Allocation; D012837:Silver Sulfadiazine / Q000008:administration & dosage*; D013411:Sulfadiazine / Q000008:administration & dosage*; D013997:Time Factors; D014945:Wound Healing
C042816:Biobrane; D001672:Biocompatible Materials; D020099:Coated Materials, Biocompatible; D009824:Ointments; D013411:Sulfadiazine; D012837:Silver Sulfadiazine